Russu, Alberto

Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: Randomized, double-blind, placebo-controlled study

Timmers, M., Streffer, J. R., Russu, A., Tominaga, Y., Shimizu, H., Shiraishi, A., Tatikola, K., Smekens, P., Börjesson-Hanson, A., Andreasen, N., et al. (2018) · Alzheimer's Research & Therapy

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 112

Maintenance dose conversion between oral risperidone and paliperidone palmitate 1 month: Practical guidance based on pharmacokinetic simulations

Russu, A., Kern Sliwa, J., Ravenstijn, P., Singh, A., Mathews, M., Kim, E., & Gopal, S. (2018) · International Journal of Clinical Practice

Schizophrenia research and treatmentPharmaceutical studies and practices

Cited by 19

Pharmacokinetic-Pharmacodynamic Characterization of Relapse Risk for Paliperidone Palmitate 1-Month and 3-Month Formulations

Russu, A., Savitz, A., Mathews, M., Gopal, S., Feng, Y., & Samtani, M. N. (2019) · Journal of Clinical Psychopharmacology

Schizophrenia research and treatmentPharmaceutical studies and practices

Cited by 8